Insider Transactions in Q1 2021 at Mesa Laboratories Inc (MLAB)
Insider Transaction List (Q1 2021)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 26
2021
|
John James Sullivan Director |
BUY
Bona fide gift
|
Indirect |
23,564
+50.0%
|
-
|
Mar 26
2021
|
John James Sullivan Director |
SELL
Bona fide gift
|
Direct |
23,564
-40.66%
|
-
|
Mar 16
2021
|
Evan Guillemin Director |
SELL
Open market or private sale
|
Direct |
720
-2.2%
|
$193,680
$269.48 P/Share
|
Mar 12
2021
|
John Sakys CFO |
SELL
Open market or private sale
|
Direct |
2,500
-36.5%
|
$657,500
$263.84 P/Share
|
Mar 12
2021
|
John Sakys CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+15.97%
|
$147,500
$59.64 P/Share
|
Mar 11
2021
|
Brian David Archbold SVP Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
145
+27.78%
|
$18,705
$129.1 P/Share
|
Mar 10
2021
|
Brian David Archbold SVP Operations |
SELL
Open market or private sale
|
Direct |
223
-59.15%
|
$60,433
$271.78 P/Share
|
Mar 01
2021
|
John James Sullivan Director |
SELL
Open market or private sale
|
Direct |
1,250
-2.11%
|
$341,250
$273.94 P/Share
|
Feb 23
2021
|
Gregory Dinoia SVP Commercial |
SELL
Open market or private sale
|
Direct |
280
-25.0%
|
$77,280
$276.75 P/Share
|
Feb 16
2021
|
Evan Guillemin Director |
SELL
Open market or private sale
|
Direct |
3,600
-9.9%
|
$1,011,600
$281.52 P/Share
|
Feb 10
2021
|
John Bradley Schmieder Director |
SELL
Open market or private sale
|
Direct |
1,750
-2.38%
|
$486,500
$278.23 P/Share
|
Feb 01
2021
|
John James Sullivan Director |
SELL
Open market or private sale
|
Direct |
1,250
-2.07%
|
$346,250
$277.67 P/Share
|
Jan 12
2021
|
John Bradley Schmieder Director |
SELL
Open market or private sale
|
Direct |
477
-0.65%
|
$135,945
$285.23 P/Share
|
Jan 08
2021
|
John Sakys CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+18.69%
|
$89,000
$89.7 P/Share
|
Jan 06
2021
|
John Sakys CFO |
SELL
Open market or private sale
|
Direct |
16
-0.48%
|
$4,640
$290.0 P/Share
|
Jan 06
2021
|
John Sakys CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
16
+0.47%
|
$1,424
$89.7 P/Share
|
Jan 04
2021
|
John James Sullivan Director |
SELL
Open market or private sale
|
Direct |
1,250
-2.03%
|
$350,000
$280.82 P/Share
|